HPV

HPV test awareness, knowledge still low

Friends, I love hearing about HPV awareness in our nation, and how great it is.  However, if only those who I see day after day with diagnosed-HPV had been as educated.

I want to stop this cycle of amazing and brilliant people getting hurt solely by not being informed.  HPV education and prevention wasn't taught in school back in the days.  So now it's up to us to share the message.  And it's up to doctor's like me to lead the pack.   Let's do this.

I got you.

-- Dr. Dale

l

HPV test awareness, knowledge still low

By Shereen Jegtvig

NEW YORK (Reuters Health) - Americans are more aware that there is a test for the human papilloma virus (HPV) than counterparts in the UK and Australia, according to a new study, but few people knew much more than that.

"Awareness of HPV has tended to be low but has been rising since the introduction of testing and vaccination," said Jo Waller, the study's senior author.

People seem to be more aware of HPV vaccination than testing, however, which is not surprising given the publicity around the vaccine, added Waller, a public health researcher at University College London.

The Pap test, used to look for abnormal cell changes in the cervix, is much older and generally familiar to most people, but the newer HPV test looks for the virus that causes those changes, Waller said.

The HPV test was only introduced in the 1990s and it's used a little differently in each of the countries that were included in the new study, Waller pointed out.

In the U.S., HPV testing is used as a screening tool in women over the age of 30. In both the U.S. and the UK, HPV testing is also used along with the Pap test to determine the next steps in treatment - for instance, biopsy.

In the UK and Australia, the HPV test is also used to monitor treatment results.

Waller said that many studies have attempted to assess the public's knowledge about HPV and HPV testing, but they all used different methods and asked questions in different ways, so it's hard to compare the findings.

"We wanted to use the same questionnaire to look at knowledge across three countries where HPV testing is used in different ways," she told Reuters Health in an email.

The researchers used an online survey to find out if participants in the U.S., UK and Australia were aware of HPV testing and HPV in general.

The first question asked was 'Before today, had you ever heard of HPV?' Participants who responded 'yes' were then directed to 15 general questions about HPV.

Participants were then asked 'Have you ever heard of HPV testing?' Those who responded 'yes' were asked six more questions about the test.

Of the 2,409 men and women who answered the survey, about 61 percent had heard of HPV, Waller's team reports in the journal Sexually Transmitted Infections.

Among those who had heard of the virus, only half were aware of the HPV test. Awareness of the HPV test was higher in the U.S. than in the UK and Australia.

The participants who had heard of HPV testing, on average, answered less than half of questions about details of testing correctly. Overall, women knew more than men.

Most of the survey participants did know, for example, that the HPV test can be done at the same time as the Pap test, and that a positive HPV test doesn't mean a woman will definitely get cervical cancer.

But they didn't know a negative HPV test indicates a low risk of cervical cancer. Few also knew that the HPV test is not an indicator of whether the HPV vaccine is needed.

"It's also important for people to understand that although the HPV vaccine protects against HPV, it's still really important for women to have screening, to check for (virus) types not covered by the vaccine," Waller said.

Women who are screened and found not to have the HPV virus should be reassured that their risk of developing cervical cancer over the next five years is extremely low, Waller added.

SOURCE: bit.ly/1aLPRNE Sexually Transmitted Infections, Online January 9, 2014.

HPV & Cervical Cancer: What You Should Know

Hi friends - this is an informative article on the HPV-cervical cancer connection.  Read this please, and if you have any concerns concerning protection, please come see me in the office or email me privately.  I got you. -- Dr. Dale

--------

When a woman's Pap smear—a test for detecting precancerous or cancerous cervical cells—is abnormal, and she is diagnosed with human papilloma virus (HPV), she may feel pretty worried. After all, each year, American women develop more than 20,000 HPV-related cancers. Cervical cancer is the most common, but HPV is also associated with other cancers such as vulva, vaginal, penile, anal and throat cancer.

While a HPV diagnosis is troubling—and certainly nothing to take lightly—in most cases, there is no need to panic. The HPV virus appears to be able to "clear" on its own in young, healthy women, so a woman who receives an abnormal Pap one year may have a normal one the following year. “At least 80 percent of young women will be HPV positive at some point,” says Mary Jane Minkin, MD, clinical professor at Yale School of Medicine’s Department of Obstetrics, Gynecology and Reproductive Sciences and author of A Woman's Guide to Sexual Health. In other words, most instances of the virus won't progress to full-blown cancer.

Still, no one can assume her body will clear the virus—particularly women ages 30 and older. Additionally, while most types of HPV resolve spontaneously, certain strains of the virus are more likely to persist and cause precancerous cell changes that can lead to cervical lesions. So the more you know about HPV and how to avoid it, the safer you’ll be. Below are ways to guard yourself against this ubiquitous sexually transmitted infection.

Get vaccinated. The U.S. Food and Drug Administration (FDA) has approved two HPV vaccines. Gardasil protects against four strains of the virus (out of more than 100), says Minkin: “The high-risk ‘baddies’ are strains 16 and 18, which account for about 70 percent of cervical cancers.  Strains 6 and 11 are responsible for yucky warts. That’s why Gardasil protects against those four.”

The other vaccine, Cervarix, protects against HPV 16 and 18 but not HPV-related warts. Both are given in three injections over six months.

“All kids—girls and boys—need to be immunized,” says Minkin. Both vaccines are approved for ages 9-25. It’s best to get the vaccine before becoming sexually active. Some insurance plans cover the vaccines, as does Medicaid, and both manufacturers also offer help for those who can’t afford them (about $130 per dose).

The vaccines are not approved for people over age 26 because studies have not shown them to be effective in older people, but women 26+ can protect themselves by getting regular screenings for HPV, following up on abnormal results, having limited sexual partners (one, preferably), and making sure any sexual partner is infection-free.

Read more: http://www.eveningtribune.com/article/20140121/NEWS/301219922/2153/LIFESTYLE#ixzz2rTxtcmUH Read more: http://www.eveningtribune.com/article/20140121/NEWS/301219922/2153/LIFESTYLE#ixzz2rTwioMAK

5 ways to die in 2014.

The Centers for Disease Control and Prevention (CDC) has announced the top 5 threats for 2014.  Check out #4.  #HPV We're two weeks into the New Year.  Let's get you checked.  Later is today.

I got you.

-- Dr. Dale

-------------

http://blogs.cdc.gov/cdcworksforyou24-7/2013/12/cdc’s-top-ten-5-health-achievements-in-2013-and-5-health-threats-in-2014/

Top 5 health threats looking ahead in 2014:

 1.  Antibiotic Resistance & Advanced Molecular Detection

Coping with untreatable infections in The End of the Antibiotic Era 

Every year, more than 2 million people in the U.S. get infections that are resistant to antibiotics and at least 23,000 people die as a result. CDC recently reported a first-ever snapshot of the burden and threats posed by the antibiotic-resistant germs that have the most impact on human health and identified four essential steps to combat antibiotic resistance. In 2014, CDC will continue to work with federal, state, and local partners towards improving antibiotic use, preventing infections and the spread of resistance, gathering data on antibiotic-resistant infections, and developing diagnostic tests to track the development of resistance. Also, with advanced molecular detection (AMD), CDC, public health partners, and healthcare facilities will be better able to track and stop the spread of drug-resistant infections in healthcare facilities, thereby protecting patients and saving lives. (Right photo: CDC microbiologist, Tatiana Travis, sets up real-time polymerase chain reaction (PCR) test to detect drug-resistant pathogens.)

2. Prescription Drug Abuse and Overdose

Reducing the number of misuse, abuse or overdose amidst a growing epidemic

Deaths from prescription painkillers have reached epidemic levels in the past decade, and more than 16,500 people died from painkiller overdoses in 2010. CDC is working to reduce the misuse, abuse and overdose of prescription painkillers while ensuring patients with pain have access to safe, effective treatment. CDC continues to track prescription drug overdosetrends to better understand the epidemic. And, in 2014, will continue to focus on comprehensive state efforts to develop, implement and evaluate promising strategies to prevent prescription drug abuse and overdose.

3. Global Health Security

Securing our global health borders knowing that disease can spread nearly anywhere within 24 hours

Infectious disease outbreaks, whether natural, intentional, or accidental, are still among the foremost dangers to human health and the global economy. With patterns of global travel and trade, disease can spread nearly anywhere within 24 hours. That’s why the ability to prevent, detect and respond to these disease threats must be developed and strengthened overseas and not just here in the U.S. Through strategic investments in critical public health systems, CDC is working with Ministries of Health to increase their ability to prepare for and respond to public health threats and reduce the risk of these threats crossing borders.

4. HPV

Preventing cancer in the U.S. by vaccinating preteens and teens  

For both boys and girls, HPV vaccination rates continue to be well below the Healthy People goals for 2020, leaving an entire generation susceptible to HPV-related cancers. CDC will continue to monitor adolescent vaccination coverage levels via the National Immunization Survey (NIS) – Teen. Additionally, we will provide technical assistance to 11 immunization program awardees that received funding to improve HPV vaccination coverage levels among adolescent girls and boys. We will also continue outreach and education to clinicians through continuing medical education, partnership with professional associations, and other educational opportunities to help strengthen vaccine recommendations and eliminate missed opportunities for HPV vaccination. Finally, utilizing partnership building and media outreach, CDC will continue awareness activities aimed at parents of 11-12 year olds to help promote understanding and uptake of HPV vaccine.

5. Polio

Coming together to end polio once and for all

The world is closer than ever to ending polio everywhere, thanks to the efforts of CDC and the Global Polio Eradication Initiative. However, challenges must be addressed in 2014 to meet the goal of eradicating polio once and for all. Insecurity is the biggest challenge. Active conflict, military operations and/or local bans on immunizations prevent polio vaccinators from reaching approximately two million children in high-risk areas. Overcoming this challenge is a critical step towards ending polio and improving the lives of the world’s most vulnerable children. Working together as part of a committed global effort, we are confident that we will be able to change history and end polio forever. (Left photo: Child polio drops in Nepal. Photo Credit: Adam Bjork, 2011)